| scholarly article | Q13442814 |
| P2093 | author name string | Jürgen Schrezenmeir | |
| Anne Berit C Samuelsen | |||
| Svein H Knutsen | |||
| P2860 | cites work | Cell wall assembly in Saccharomyces cerevisiae | Q24549234 |
| Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of beta-glucan | Q28203700 | ||
| Immune recognition. A new receptor for beta-glucans | Q28215606 | ||
| Orally administered marine (1-->3)-beta-D-glucan Phycarine stimulates both humoral and cellular immunity | Q28264003 | ||
| Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models | Q28270755 | ||
| Analysis of alkali-soluble glucan produced by Saccharomyces cerevisiae wild-type and mutants | Q31047784 | ||
| Orally Administered Particulate β-Glucan Modulates Tumor-Capturing Dendritic Cells and Improves Antitumor T-Cell Responses in Cancer | Q34267746 | ||
| Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge | Q34558787 | ||
| Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer. | Q34573203 | ||
| Bread, beer and wine: Saccharomyces cerevisiae diversity reflects human history | Q34627793 | ||
| Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans | Q35083249 | ||
| Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers | Q36347902 | ||
| Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action | Q37126054 | ||
| Yeast (1,3)-(1,6)-beta-glucan helps to maintain the body's defence against pathogens: a double-blind, randomized, placebo-controlled, multicentric study in healthy subjects | Q37321722 | ||
| Potential of the beta-glucans to enhance innate resistance to biological agents | Q37700561 | ||
| Chemistry, physico-chemistry and applications linked to biological activities of β-glucans | Q37829352 | ||
| Do cereal mixed-linked β-glucans possess immune-modulating activities? | Q38001979 | ||
| Effects of glucan on immunosuppressive actions of mercury | Q39783394 | ||
| Oral administration of a soluble 1-3, 1-6 beta-glucan during prophylactic survivin peptide vaccination diminishes growth of a B cell lymphoma in mice | Q39815194 | ||
| Cell wall beta-(1,6)-glucan of Saccharomyces cerevisiae: structural characterization and in situ synthesis | Q42159503 | ||
| The structure of a beta-(1 leads to 3)-D-glucan from yeast cell walls | Q42557047 | ||
| Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'. | Q42723848 | ||
| Relationship between the physical properties of Candida albicans cell well beta-glucan and activation of leukocytes in vitro | Q44154145 | ||
| Oral beta-glucan protects kidney against ischemia/reperfusion injury in rats | Q46932538 | ||
| Scientific Opinion on the safety of ‘yeastbeta-glucans’ as a Novel Food ingredient | Q47149920 | ||
| Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage | Q47179682 | ||
| Oral β-glucan reduces infarction size and improves regional contractile function in a porcine ischaemia/reperfusion model | Q47333368 | ||
| Plant immunostimulants--scientific paradigm or myth? | Q47376538 | ||
| Stressful life events are associated with low secretion rates of immunoglobulin A in saliva in the middle aged and elderly | Q47754765 | ||
| Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans. | Q47894969 | ||
| Oral administration of beta-1,3/1,6-glucan Macrogard fails to enhance the mucosal immune response following oral F4 fimbrial immunisation in gnotobiotic pigs. | Q49090912 | ||
| Influence of yeast-derived 1,3/1,6 glucopolysaccharide on circulating cytokines and chemokines with respect to upper respiratory tract infections. | Q50954043 | ||
| Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity | Q56607718 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 183-193 | |
| P577 | publication date | 2013-09-10 | |
| P1433 | published in | Molecular Nutrition and Food Research | Q15751861 |
| P1476 | title | Effects of orally administered yeast-derived beta-glucans: a review | |
| P478 | volume | 58 |
| Q61444224 | A combination of yeast beta-glucan and milk hydrolysate is a suitable alternative to zinc oxide in the race to alleviate post-weaning diarrhoea in piglets |
| Q38274758 | A perspective on the use of Pleurotus for the development of convenient fungi-made oral subunit vaccines |
| Q39458900 | Biotechnological application of yeasts in food science: Starter cultures, probiotics and enzyme production |
| Q49964363 | Cancer Chemopreventive, Antiproliferative, and Superoxide Anion Scavenging Properties of Kluyveromyces marxianus and Saccharomyces cerevisiae var. boulardii Cell Wall Components |
| Q98946379 | Development of an in vitro macrophage screening system on the immunomodulating effects of feed components |
| Q37535439 | Exercise and Beta-Glucan Consumption (Saccharomyces cerevisiae) Improve the Metabolic Profile and Reduce the Atherogenic Index in Type 2 Diabetic Rats (HFD/STZ). |
| Q92164172 | Feed additive blends fed to nursery pigs challenged with Salmonella |
| Q53697469 | Macrophage-Targeted Therapeutics for Metabolic Disease. |
| Q52657150 | Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles. |
| Q35953414 | Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial |
| Q40394443 | Orally delivered β-glucans aggravate dextran sulfate sodium (DSS)-induced intestinal inflammation |
| Q27001699 | Recent advances in oral vaccine development: yeast-derived β-glucan particles |
| Q99630564 | Role of nutraceuticals during the transition period of dairy cows: a review |
| Q26796416 | Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review |
| Q47195452 | Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer. |
| Q90533360 | Targeted Delivery of Cisplatin-Derived Nanoprecursors via a Biomimetic Yeast Microcapsule for Tumor Therapy by the Oral Route |
| Q58741982 | The scale-up cultivation of Candida utilis in waste potato juice water with glycerol affects biomass and β(1,3)/(1,6)-glucan characteristic and yield |
| Q98771940 | Treatment With Hydrolyzed Diet Supplemented With Prebiotics and Glycosaminoglycans Alters Lipid Metabolism in Canine Inflammatory Bowel Disease |
| Q26752288 | Vitamin D and airway infections: a European perspective |
| Q38691189 | Yeast capsules for targeted delivery: the future of nanotherapy? |
| Q27301038 | β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease |
Search more.